NBTX Competitors & Alternatives
Compare Nanobiotix with similar stocks in the same industry
Biotechnology
NBTX
Main Stock$51.50
Tradestie Score
58
Market Cap
$903.54M
Revenue Growth
1.9%
Analyst Upside
-34.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$25.00
|
$2.89B | - | 55 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$27.49
|
$2.85B | - | 60 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.18
|
$2.56B | 18.0 | 60 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$27.93
|
$2.44B | - | 59 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$62.48
|
$2.42B | - | 59 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$143.00
|
$2.41B | - | 46 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$28.21
|
$2.40B | - | 59 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
More NBTX Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry